RecruitingNot ApplicableNCT06685211

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

A Randomized, Sham Controlled, Masked Study to Evaluate the Efficacy of Alternating Current Stimulation Using the Eyetronic System for the Treatment of Glaucoma


Sponsor

Stanford University

Enrollment

30 participants

Start Date

Jul 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether electrical stimulation of the eye and brain — using small electrodes placed on the skin near the eye — can improve vision in people with glaucoma, a disease that damages the optic nerve and narrows the visual field. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with open-angle glaucoma with moderate vision loss - Your eye pressure is controlled and stable (below 18 mmHg) - You are able to follow the study schedule and procedures **You may NOT be eligible if...** - You have a history of eye herpes, corneal cloudiness, or eye inflammation - You are taking systemic steroids or other immune-suppressing drugs - You have a pacemaker, metal implants in the skull, or have had brain surgery - You have epilepsy or a history of seizures - You are pregnant or breastfeeding - You have uncontrolled high blood pressure or eye pressure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEyetronic rtACS

The repetitive, transorbital alternating current stimulation (rtACS) is a device for non-invasive Interventional Neurophysiology. The electrical charge and current density applied during rtACS safe and able to modulate existing neuronal elements in the eye and brain.

DEVICESham rtACS

Participants will wear the Eyetronic system but there will be no active stimulations applied.


Locations(1)

Byers Eye Institute at Stanford University

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06685211


Related Trials